粒体自噬
自噬
细胞生物学
线粒体
移植
化学
串扰
白藜芦醇
心肌保护
线粒体ROS
活性氧
mTORC1型
内化
溶酶体
促炎细胞因子
胞浆
生物
程序性细胞死亡
细胞保护
焊剂(冶金)
细胞内
线粒体生物发生
再灌注损伤
信号转导
炎症
作者
Nisha Wang,Qiyang Ding,Lei Shi,Ji Xia,Shuyue Zhang,Chenxin Jian,Yixiao Yan,Xiuhua Luo,Jiarui Wang,Ming Cheng,Y F Jia,Hao Tian,Wei Gao
标识
DOI:10.1002/advs.202518969
摘要
Mitochondrial transplantation has emerged as a promising therapeutic intervention for ischemic strokes (IS). Although previous studies have demonstrated the therapeutic breakthroughs of mitochondrial transplantation facilitated by advances in biotechnology, in-depth investigations into the exact mechanisms underlying its beneficial effects remain insufficient. Here, we investigate how exogenous mitochondria interact with recipient cells to optimize therapeutic protocols and improve outcomes. Emerging evidence indicates that exogenous mitochondria act as triggers of mitophagy via the PTEN-induced putative kinase 1 (PINK1)-Parkin pathway. However, excessive reactive oxygen species (ROS) generated during ischemia-reperfusion injury activate the receptor-interacting protein (RIP)1/RIP3 pathway, leading to the blockage of autophagic flux. Hence, we devised a novel mitochondrial transplantation platform (MLSR) that utilizes functionalized starch as a stable coating for exogenous mitochondria and enables the co-delivery of the antioxidant resveratrol through the helical structure of the starch. Following internalization by recipient neurons, the exogenous mitochondria rapidly initiate mitophagy, while resveratrol escapes from the lysosome to inhibit the ROS-RIP1/RIP3-exosome axis. Experimental results demonstrate that MLSR effectively triggers and maintains positive autophagic flux, thereby suppressing the release of undegraded autophagosomes in the form of exosomes and preventing proinflammatory crosstalk between neurons and microglia. Therefore, our findings provide important implications for renewing the therapeutic potential of mitochondrial transplantation.
科研通智能强力驱动
Strongly Powered by AbleSci AI